Home > News > Company News > Corning, SGD Pharma to Open New Glass Tubing Facility in India

Corning, SGD Pharma to Open New Glass Tubing Facility in India

Post Time:Jun 13,2023Classify:Company NewsView:1028

Corning and SGD Pharma have announced a joint venture that includes the opening of a new glass tubing facility to expand pharmaceutical manufacturing in India and allows SGD Pharma to adopt Corning’s Velocity® vial technology platform.

Combining SGD Pharma’s vial-converting expertise with Corning’s proprietary glass-coating technology, the collaboration will enhance vial quality, improve filling-line productivity, and speed the global delivery of injectable treatments.

SGD Pharma and Corning have broken ground on the new pharmaceutical glass tubing facility in Telangana, India. Manufacturing of Velocity vials at the facility is expected to begin in 2024. Pharmaceutical tubing production is projected to begin the following year.

The partnership with Corning represents yet another step in our strategy to advance converting technology in the pharmaceutical industry and secure our supply chain. The introduction of Velocity vials will contribute to the ongoing evolution of our offerings and services and will expand our portfolio of high-quality tubular glass packaging,” says Olivier Rousseau, SGD Pharma CEO. “We see an opportunity for the industry to improve drug filling quality and performance capabilities by transitioning to Corning’s coated vial technology.”

SGD Pharma joins a growing network of leading primary packaging manufacturers adopting Corning’s cutting-edge coating technology. The joint venture expands Velocity vials’ manufacturing footprint, localizes its supply chains in India, and enables easier adoption of the technology by customers.

“Corning is advancing pharmaceutical glass technology to help our customers address their most pressing challenges—globally and locally,” says Ron Verkleeren, senior vice president and general manager of Corning’s Life Sciences Market Access Platform. “The joint venture with SGD Pharma supports our continued global expansion as we localize manufacturing for our customers. The collaboration also strengthens our leadership position in the industry and underscores our commitment to India’s high-growth market.”

Source: https://www.healthcarepackaging.com/Author: shangyi

Hot News

返回顶部